Literature DB >> 16154251

Tuberculosis and pregnancy--Results of a study in a high prevalence area in London.

Anjali Kothari1, Neila Mahadevan, Joanna Girling.   

Abstract

OBJECTIVE: The aim of the study was to characterise the incidence, type and presentation of tuberculosis in pregnancy over a 5-year period in women booked for antenatal care in a District General Hospital located in a high prevalence area in London. We also aimed to identify any problems and difficulties in the diagnosis and management of tuberculosis associated with pregnancy.
DESIGN: Retrospective review of computer records and hospital notes over a period of 5 years from January 1997 to December 2001. Demographic and clinical data were collected for all the cases identified. POPULATION: All women with tuberculosis who conceived on antituberculous treatment, or had onset of symptoms or diagnosis made in pregnancy or the immediate postpartum period (6 weeks), and booked for antenatal care at a District General Hospital located in an area of high prevalence for tuberculosis (52.2 per 100,000 population in Ealing, Hammersmith and Hounslow Health authority according to the National Tuberculosis Survey of England and Wales in 1998).
RESULTS: Thirty-two women were identified over the 5-year period, giving an incidence of 252/100,000 deliveries. The number of cases increased from 3 in 1997 to 10 in each of 2000 and 2001. All of these women were from ethnic minorities and 88% of them were immigrants with the median interval from arrival in UK being 2 years. Fifty-three percent were diagnosed with extrapulmonary tuberculosis, 38% with pulmonary tuberculosis and 9% had both. The median duration of symptoms prior to presentation was 31 days (being longer in women with extrapulmonary tuberculosis); the longest was 10 years. The median interval from presentation of symptoms to diagnosis was 32 days and the majority of women started treatment immediately. The commonest reason for a delay in diagnosis was late presentation (52%), followed by non-specific symptoms (in 38%). There was a trend towards late presentation among recent immigrants (odds ratio 2.14, 95% confidence interval 0.44-10.53) and those having extrapulmonary tuberculosis (odds ratio 1.64, 95% CI 0.32-8.45). Most of the women (28/32) showed good compliance and a good response to treatment (31/32). Maternal outcomes were good with no serious morbidity or mortality. The majority of women delivered at term (28/32), while two delivered preterm and two women miscarried. There was no perinatal mortality.
CONCLUSION: This is the largest recent series of pregnant women with tuberculosis in the UK. A high incidence of extrapulmonary tuberculosis was seen. The common causes for a delay in diagnosis were late presentation and non-specific symptoms. If recent immigrants from high prevalence areas who have been in the UK for less than 5 years were asked for symptoms suggestive of tuberculosis at the booking visit and through pregnancy, this might facilitate early diagnosis and treatment. The use of a symptom questionnaire at the booking visit for these women could be a method to alert both the women and health professionals involved in their care, to the symptoms of tuberculosis. With good compliance, there is a good response to treatment and favourable maternal and perinatal outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154251     DOI: 10.1016/j.ejogrb.2005.07.025

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  13 in total

1.  Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.

Authors:  L M Cranmer; A Langat; K Ronen; C J McGrath; S LaCourse; J Pintye; B Odeny; B Singa; A Katana; L Nganga; J Kinuthia; G John-Stewart
Journal:  Int J Tuberc Lung Dis       Date:  2017-03-01       Impact factor: 2.373

2.  Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa.

Authors:  Celine R Gounder; Nikolas I Wada; Caroline Kensler; Avy Violari; James McIntyre; Richard E Chaisson; Neil A Martinson
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

3.  Detecting tuberculosis in pregnant and postpartum women in Eswatini.

Authors:  Munyaradzi Pasipamire; Edward Broughton; Mandzisi Mkhontfo; Gugu Maphalala; Batsabile Simelane-Vilane; Samson Haumba
Journal:  Afr J Lab Med       Date:  2020-07-30

Review 4.  Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis.

Authors:  Kirsty Le Doare; Nathaniel Barber; Katja Doerholt; Mike Sharland
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 5.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

6.  Congenital transmission of multidrug-resistant tuberculosis.

Authors:  Nora Espiritu; Lino Aguirre; Oswaldo Jave; Luis Sanchez; Daniela E Kirwan; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2014-05-12       Impact factor: 2.345

7.  Investigation of Toll-Like Receptor-2 (2258G/A) and Interferon Gamma (+874T/A) Gene Polymorphisms among Infertile Women with Female Genital Tuberculosis.

Authors:  Venkanna Bhanothu; Vemu Lakshmi; Jane P Theophilus; Roya Rozati; Prabhakar Badhini; Boda Vijayalaxmi
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 8.  Tuberculosis care for pregnant women: a systematic review.

Authors:  Hang Thanh Nguyen; Chiara Pandolfini; Peter Chiodini; Maurizio Bonati
Journal:  BMC Infect Dis       Date:  2014-11-19       Impact factor: 3.090

9.  Risk of Adverse Infant Outcomes Associated with Maternal Tuberculosis in a Low Burden Setting: A Population-Based Retrospective Cohort Study.

Authors:  Sylvia M LaCourse; Sharon A Greene; Elizabeth E Dawson-Hahn; Stephen E Hawes
Journal:  Infect Dis Obstet Gynecol       Date:  2016-02-16

Review 10.  Female genital tuberculosis: Revisited.

Authors:  Jai Bhagwan Sharma; Eshani Sharma; Sangeeta Sharma; Sona Dharmendra
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.